Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

NovaBay Pharmaceuticals, Inc. Common Stock (NY:NBY)

2.120 +1.520 (+253.33%)
Streaming Delayed Price Updated: 10:27 AM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovaBay Pharmaceuticals, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
What's Going On With NovaBay Pharmaceuticals Shares Friday? ↗
NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals. 
Via Benzinga
News headline image
NBY Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NovaBay Pharmaceuticals, Inc.’s Avenova Brand and Business Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NBY Stock Earnings: NovaBay Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
NBY stock results show that NovaBay Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
What's Going On With NovaBay Pharmaceuticals (NBY) Stock? ↗
NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of its public offering. 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Why NovaBay Pharmaceuticals (NBY) Stock Is Down 60% ↗
NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its public offering. 
Via Benzinga
News headline image
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results ↗
 
Via Benzinga
News headline image
Dow Surges 550 Points; Headline PCE Price Index Falls To 2.5% ↗
 
Via Benzinga
Topics Stocks
News headline image
NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday! 
Via InvestorPlace
News headline image
Why Ultra Clean Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning! 
Via InvestorPlace
News headline image
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
News headline image
Gold Gains 1%; Best Buy Posts Upbeat Earnings ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.